ITPA and acute lymphoblastic leukemia: The occurrence of toxicities during the ALL maintenance therapy was previously associated with ITPA variants: in the context of the SJCRH Total XIIIB protocol, Stocco et al.[59] found that ALL patients with a variant ITPA allele had a higher probability of developing severe febrile neutropenia.